Jazz Pharms Inc Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the competitive landscape for JAZZ PHARMS INC, and when can generic versions of JAZZ PHARMS INC drugs launch?
JAZZ PHARMS INC has one approved drug.
There are two US patents protecting JAZZ PHARMS INC drugs.
There are twenty-four patent family members on JAZZ PHARMS INC drugs in sixteen countries.
Drugs and US Patents for Jazz Pharms Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jazz Pharms Inc | DEFITELIO | defibrotide sodium | SOLUTION;INTRAVENOUS | 208114-001 | Mar 30, 2016 | RX | Yes | Yes | 11,085,043 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Jazz Pharms Inc | DEFITELIO | defibrotide sodium | SOLUTION;INTRAVENOUS | 208114-001 | Mar 30, 2016 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Jazz Pharms Inc | DEFITELIO | defibrotide sodium | SOLUTION;INTRAVENOUS | 208114-001 | Mar 30, 2016 | RX | Yes | Yes | 11,236,328 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Jazz Pharms Inc Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Denmark | 2864496 | ⤷ Try a Trial |
South Korea | 20190112197 | ⤷ Try a Trial |
European Patent Office | 2864496 | ⤷ Try a Trial |
Singapore | 11201408481U | ⤷ Try a Trial |
South Korea | 20150044877 | ⤷ Try a Trial |
South Korea | 20190016148 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.